Europe — EMA
Nitroglycerin Karo Pharma (Glyceryl Trinitrate)
GNH USA supplies Nitroglycerin Karo Pharma (Glyceryl Trinitrate), a nitrate vasodilator for acute angina, heart failure and hypertensive emergencies.
Request sourcing
What is Glyceryl Trinitrate?
Glyceryl trinitrate, the active ingredient in Nitroglycerin Karo Pharma, is a nitrate vasodilator presented as an injectable solution for intravenous use. It treats acute angina pectoris, heart failure and hypertensive emergencies in adult patients.
GNH USA supplies Nitroglycerin Karo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Glyceryl Trinitrate used for?
Nitroglycerin Karo Pharma, a nitrate vasodilator, is used in conditions where rapid reduction of cardiac workload is required.
Acute angina pectoris: rapid relief of chest pain by improving coronary blood flow. Heart failure: reduction of preload and afterload to ease ventricular workload. Hypertensive emergencies: prompt blood pressure lowering through systemic vasodilation.
What are the side effects of Glyceryl Trinitrate?
Nitroglycerin Karo Pharma may cause several adverse reactions.
Common Side Effects: - Headache - Flushing - Hypotension - Dizziness
Serious or Rare Side Effects: - Severe hypotension - Methemoglobinemia - Allergic reaction (anaphylaxis)
What precautions apply to Glyceryl Trinitrate?
Use of Nitroglycerin Karo Pharma requires careful clinical monitoring.
Monitor blood pressure: check frequently after initiation and dose adjustments. Avoid concurrent nitrates: combined use can cause profound hypotension. Do not combine with phosphodiesterase‑5 inhibitors: risk of severe vasodilation. Use cautiously in anemia or hypovolemia: may exacerbate low oxygen delivery. Store at room temperature: keep in original container, protect from moisture and light.
What does Glyceryl Trinitrate interact with?
Nitroglycerin Karo Pharma interacts with several drug classes.
Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe hypotension. - Other nitrates or nitric‑oxide donors: additive vasodilatory effect. - Alcohol: may enhance hypotensive response.
Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia. - Diuretics: can increase risk of volume depletion and hypotension. - Calcium‑channel blockers: may potentiate blood pressure lowering.



